Skip to content
CES 2027
CES
2027

WE, COSMAS BIOSCIENCE

Company

Breakthrough Technology Overview

We deliver personalized precision medicine and early diagnostics worldwide through a high-sensitivity, point-of-care multiplex platform. By integrating cutting-edge BT, NT, and ICT, we've developed world-class breakthrough core technology.

Portable Molecular Diagnostic
Platform

Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device, Nat. Biomed. Eng. 4, 1159–1167 (2020)

Nature Biomedical Engineering research figure
Nature Biomedical Engineering publication detail

Ultra-sensitive Saliva-based
Immunoassay Solution

A rapid assay provides on-site quantification of tetrahydrocannabinol in oral fluid, Sci. Transl. Med. 13, abe2352 (2021)

Science Translational Medicine research figure
Science Translational Medicine publication detail